Clinical Trial: A Phase Ib Study to Evaluate the Efficacy and Safety of HRS-2129 in Patients With Knee Osteoarthritis

U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07351968) titled 'A Phase Ib Study to Evaluate the Efficacy and Safety of HRS-2129 in Patients With Knee Osteoarthritis' on Jan. 11.

Brief Summary: Primary Objective: To explore the effectiveness of different doses of HRS-2129 in the treatment of patients with moderate to severe pain in knee osteoarthritis. Secondary Objectives: To evaluate the safety of different doses of HRS-2129 for the treatment of patients with moderate to severe pain in knee osteoarthritis; To evaluate the population pharmacokinetic profile of HRS-2129 in patients with knee osteoarthritis.

Study Start Date: March, 2026

Study Type: INTERVENTIONAL

Condition: Moderate and Seve...